| Literature DB >> 24267683 |
Jeffrey C Phillips1, Luis M Lembcke.
Abstract
Melanomas are among the most common skin tumors in horses, with prevalence rates reaching as high as 80% in adult gray horses. Most melanocytic tumors are benign at initial presentation; however, if left untreated, up to two-thirds can progress to overt malignant behavior. Standard local treatment options can be used to treat solitary early-stage lesions but do not address the underlying risk of recurrent tumor formation or the transformation to a malignant phenotype. An understanding of the specific molecular genetic factors associated with tumor formation should lead to targeted therapies that can be used to treat or ideally prevent disease.Entities:
Keywords: Chemotherapy; Genetics; Horse; Immunotherapy; Melanoma; Treatment; Vaccine
Mesh:
Year: 2013 PMID: 24267683 DOI: 10.1016/j.cveq.2013.08.008
Source DB: PubMed Journal: Vet Clin North Am Equine Pract ISSN: 0749-0739 Impact factor: 1.792